Lucira Health Inc
Prices are adjusted according to historical splits.
Vitals
- Today's Low:
- $0.0302
- Today's High:
- $0.038
- Open Price:
- $0.0302
- 52W Low:
- $0.025
- 52W High:
- $1.849
- Prev. Close:
- $0.042
- Volume:
- 90481
Company Statistics
- Market Cap.:
- $18.36 million
- Book Value:
- 1.505
- Revenue TTM:
- $212.13 million
- Operating Margin TTM:
- -64.94%
- Gross Profit TTM:
- $11.66 million
- Profit Margin:
- -67.54%
- Return on Assets TTM:
- -41.8%
- Return on Equity TTM:
- -112.43%
Company Profile
Lucira Health Inc had its IPO on 2021-02-05 under the ticker symbol LHDX.
The company operates in the Healthcare sector and Healthcare Equipment & Supplies industry. Lucira Health Inc has a staff strength of 221 employees.
Stock update
Shares of Lucira Health Inc opened at $0.03 at the start of the last trading session i.e. 2023-09-12.
The stocks traded within a range of $0.03 - $0.04, and closed at $0.03.
This is a -19.29% slip from the previous day's closing price.
A total volume of 90,481 shares were traded at the close of the day’s session.
In the last one week, shares of Lucira Health Inc have slipped by -3.14%.
Lucira Health Inc's Key Ratios
Lucira Health Inc has a market cap of $18.36 million, indicating a price to book ratio of 0.1901 and a price to sales ratio of 0.0392.
In the last 12-months Lucira Health Inc’s revenue was $212.13 million with a gross profit of $11.66 million and an EBITDA of $-131231000. The EBITDA ratio measures Lucira Health Inc's overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, Lucira Health Inc’s operating margin was -64.94% while its return on assets stood at -41.8% with a return of equity of -112.43%.
In Q3, Lucira Health Inc’s quarterly earnings growth was a positive 0% while revenue growth was a positive 129.6%.
Lucira Health Inc’s PE and PEG Ratio
- Forward PE
- 0
- Trailing PE
- 0
- PEG
Its diluted EPS in the last 12-months stands at $-3.14 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Lucira Health Inc’s profitability.
Lucira Health Inc stock is trading at a EV to sales ratio of 0.0938 and a EV to EBITDA ratio of -0.1477. Its price to sales ratio in the trailing 12-months stood at 0.0392.
Lucira Health Inc stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.
Balance sheet and cash flow metrics
- Total Assets
- $189.19 million
- Total Liabilities
- $82.52 million
- Operating Cash Flow
- $-7174000.00
- Capital Expenditure
- $7.17 million
- Dividend Payout Ratio
- 0%
Lucira Health Inc ended 2024 with $189.19 million in total assets and $0 in total liabilities. Its intangible assets were valued at $189.19 million while shareholder equity stood at $60.89 million.
Lucira Health Inc ended 2024 with $0 in deferred long-term liabilities, $82.52 million in other current liabilities, 40000.00 in common stock, $-264002000.00 in retained earnings and $0 in goodwill. Its cash balance stood at $39.77 million and cash and short-term investments were $39.77 million. The company’s total short-term debt was $2,316,000 while long-term debt stood at $29.41 million.
Lucira Health Inc’s total current assets stands at $120.47 million while long-term investments were $0 and short-term investments were $0. Its net receivables were $19.22 million compared to accounts payable of $25.17 million and inventory worth $55.63 million.
In 2024, Lucira Health Inc's operating cash flow was $-7174000.00 while its capital expenditure stood at $7.17 million.
Comparatively, Lucira Health Inc paid $0 in dividends in 2024.
Other key metrics
- Current Trading Price
- $0.03
- 52-Week High
- $1.849
- 52-Week Low
- $0.025
- Analyst Target Price
- $0.5
Lucira Health Inc stock is currently trading at $0.03 per share. It touched a 52-week high of $1.849 and a 52-week low of $1.849. Analysts tracking the stock have a 12-month average target price of $0.5.
Its 50-day moving average was $0.24 and 200-day moving average was $0.88 The short ratio stood at 0.24 indicating a short percent outstanding of 0%.
Around 1012.7% of the company’s stock are held by insiders while 2390% are held by institutions.
Frequently Asked Questions About Lucira Health Inc
Similar Industry Stocks (Healthcare Equipment & Supplies)
Most Active
Top Gainers
Top Losers
About
Lucira Health, Inc., a medical technology company, focuses on the development and commercialization of infectious disease test kits. It develops a testing platform that produces molecular testing services. The company offers LUCIRA COVID-19 All-In-One Test Kit, a COVID-19 test kit; and develops influenza A and B viruses test kits. It has a patent license agreement with Eiken Chemical Co., Ltd.; technical services agreement with Jabil, Inc.; and manufacturing services agreement with Jabil MSA. The company was formerly known as DiAssess Inc. and changed its name to Lucira Health, Inc. in January 2020. Lucira Health, Inc. was incorporated in 2013 and is headquartered in Emeryville, California. On February 22, 2023, Lucira Health, Inc., filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware.